BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 21652783)

  • 1. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
    Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
    J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.
    Kuno A; Tanno M; Horio Y
    Ann N Y Acad Sci; 2015 Aug; 1348(1):46-54. PubMed ID: 26109180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
    Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
    Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol Decreases Oxidative Stress by Restoring Mitophagy and Improves the Pathophysiology of Dystrophin-Deficient
    Sebori R; Kuno A; Hosoda R; Hayashi T; Horio Y
    Oxid Med Cell Longev; 2018; 2018():9179270. PubMed ID: 30510631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.
    Gordon BS; Delgado Díaz DC; Kostek MC
    Clin Nutr; 2013 Feb; 32(1):104-11. PubMed ID: 22795790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy.
    Desguerre I; Arnold L; Vignaud A; Cuvellier S; Yacoub-Youssef H; Gherardi RK; Chelly J; Chretien F; Mounier R; Ferry A; Chazaud B
    Muscle Nerve; 2012 Jun; 45(6):803-14. PubMed ID: 22581532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis.
    Ljubicic V; Burt M; Lunde JA; Jasmin BJ
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C66-82. PubMed ID: 24760981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
    Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
    Taniguti AP; Pertille A; Matsumura CY; Santo Neto H; Marques MJ
    Muscle Nerve; 2011 Jan; 43(1):82-7. PubMed ID: 21108244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies.
    Terrill JR; Radley-Crabb HG; Iwasaki T; Lemckert FA; Arthur PG; Grounds MD
    FEBS J; 2013 Sep; 280(17):4149-64. PubMed ID: 23332128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
    Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
    Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice.
    Spassov A; Gredes T; Gedrange T; Lucke S; Morgenstern S; Pavlovic D; Kunert-Keil C
    Eur J Orthod; 2011 Dec; 33(6):613-9. PubMed ID: 21187529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients.
    Nakayama Y; Nara N; Kawakita Y; Takeshima Y; Arakawa M; Katoh M; Morita S; Iwatsuki K; Tanaka K; Okamoto S; Kitamura T; Seki N; Matsuda R; Matsuo M; Saito K; Hara T
    Am J Pathol; 2004 May; 164(5):1773-82. PubMed ID: 15111323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice.
    Mok E; Constantin B; Favreau F; Neveux N; Magaud C; Delwail A; Hankard R
    Pediatr Res; 2008 Mar; 63(3):268-73. PubMed ID: 18287965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
    Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: impact of pirfenidone.
    Gosselin LE; Williams JE; Personius K; Farkas GA
    Muscle Nerve; 2007 Feb; 35(2):208-16. PubMed ID: 17058274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
    Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
    J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. uPA deficiency exacerbates muscular dystrophy in MDX mice.
    Suelves M; Vidal B; Serrano AL; Tjwa M; Roma J; López-Alemany R; Luttun A; de Lagrán MM; Díaz-Ramos A; Jardí M; Roig M; Dierssen M; Dewerchin M; Carmeliet P; Muñoz-Cánoves P
    J Cell Biol; 2007 Sep; 178(6):1039-51. PubMed ID: 17785520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.